MedTrace Logo

Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)

NCT05419648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2025-07-30

No results posted yet for this study

Summary

Myeloproliferative neoplasms (MPN) are hematological malignancies associated with a major risk of thrombosis. Monocytes are hematopoietic cells with a central role in thrombosis. An activation of monocytes has been demonstrated in MPN patients. However, their study in MPN and their thrombotic complications has never been performed. In this study, we aim to evaluate the association between monocytes sub-populations and thrombotic risk in MPN patients.

Conditions

  • Myeloproliferative Neoplasm

Interventions

BIOLOGICAL

1 additional tube of blood

For all the patients included, a specific blood sampling will be performed in addition to the classical evaluations that are performed in routine practice

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Olivier MANSIER · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-05
Primary Completion
2024-07-22
Completion
2025-07-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05419648 on ClinicalTrials.gov